Oil Prices Decline Amid Iran Tensions Airline Stocks Rally on Lower Fuel Costs China Confirms Order for 200 Boeing Jets Aviation Seen as Key Area for US Cooperation US Prioritizes American AI Expansion in Asia Following TrumpXi Summit CXMT Reports Strong Growth Figures Amid IPO Ambitions French Presidential Race CentreRight Candidate Edouard Philippe Emerges as Early Favorite to Counter Populist Rivals Quantum Computing Stocks Rally on US Government Funding Big Tech Absence Raises Questions MOMO Q4 2025 Earnings EPS Misses Estimates by 4529 as Stock Rises 151 Golden Entertainment Inc GDEN Q4 2025 Earnings Significant EPS Miss as Company Reports Unexpected Loss Main Street Capital Corporation MAIN Q1 2026 Earnings EPS Miss Weighs on Shares MNPR Q1 2026 Earnings Surprise EPS Beat in PreRevenue Biotech OilDri Corporation ODC Q1 2026 Earnings EPS of 094 Reflects Stable Operations Shares Ease SCSC Q1 2026 Earnings Narrow EPS Miss Slightly Below Estimates Stock Rises 328 Eastern Bankshares EBC Gains 18 as Stock Nears Key Technical Resistance KRAKacquisition Corp KRAQ Hovers Near Trust Value Amid Low Volume Trading TherapeuticsMD TXMD Edges Higher as Support Holds Near 201 CAMP4 Therapeutics CAMP Rallies 25 Approaching Key Resistance Level KRAKacquisition Corp KRAQ Holds Steady at 991 as Key Levels Narrow Consumer Prices Rise 38 in April Marking Highest Inflation Since May 2023 SPG Q1 2026 Earnings Slight EPS Miss Amid Stable Retail Fundamentals ServiceNow Inc NOW Rises 189 as Stock Approaches Key Resistance Sabine Royalty Trust SBR Q3 2009 Earnings EPS Misses Estimates Amid Weaker Energy Prices Sensata Technologies ST Q1 2026 Earnings Slight EPS Beat as Management Highlights Operational Discipline CCNE Q1 2026 Earnings Earnings Beat Expectation as Net Interest Margin Holds Steady Duke Energy DUKB Q1 2026 Earnings Adjusted EPS Beats Estimates Amid Steady Utility Performance Credicorp Ltd BAP Q4 2025 Earnings EPS Misses Estimates Amid Mixed Operating Conditions Pearl Diver Credit Company Inc 800 Series A Preferred Stock Due 2029 PDPA Q4 2025 Earnings Preferred EPS Misses Estimates as Credit Market Headwinds Emerge Sarepta Therapeutics Q1 2026 Earnings Robust EPS Beat Amid Modest Market Caution